SOURCE: Pro-Pointer, Inc.

Pro-Pointer, Inc.

September 14, 2009 09:55 ET

Pro-Pointer, Inc. Appoints Nickolaos D. Skouras, Ph.D., to Its Board of Directors

LAS VEGAS, NV--(Marketwire - September 14, 2009) - Pro Pointer, Inc. (PINKSHEETS: PPII) today announced the appointment of Nickolaos D. Skouras, Ph.D., to its Board of Directors. "We are very excited about our recent acquisition of Coenzyme-A Technologies and the appointment of Dr. Nick to our Board of Directors," stated Mark Pollard, President of Pro-Pointer, Inc. "Together, as a result of this new alliance, we are confident we will achieve new found success with the Coenzyme-A Technologies line of products due to increased awareness, sales, distribution, and the overall exposure to the investment community."

ABOUT COENZYME-A TECHNOLOGIES, INC. -- Coenzyme-A Technologies, Inc. is an innovative company that has applied new technology to the formulation and manufacture of a series of proprietary products which address nutritional deficiencies that result from the stress of modern day living, chemical imbalances within the body, and the effects of aging. Coenzyme-A is the first nutraceutical product to combine nutritional components that can be successfully used by the body to support its manufacture and utilization of cellular Coenzyme-A (The Master Coenzyme). Coenzyme-A contains a specific set of substrates that are designed to assist the body in converting fats, carbohydrates and proteins into energy at the cellular level. See Company website -- http://www.coenzyme-a.com/.

FORWARD LOOKING STATEMENTS

The information contained in this news release, other than historical information, consists of forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. These statements may involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. Such forward-looking statements involve known and unknown risks and uncertainties, including all business uncertainties relating to product development, marketing, market acceptance, future capital requirements, competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. The Company is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements whether as a result of new information, future events or otherwise.

Contact Information

  • INVESTOR RELATIONS:
    InvestSource, Inc.
    4041 Warner Ave. Suite F416
    Huntington Beach, CA 92647
    Phone (714) 847-2460
    Fax: (714) 847-2460